Skip to content

Article: Nicotinamide Riboside Ameliorates Senescence-Associated Alterations in Gastric Parietal Cells: Preclinical Findings

Nicotinamide Riboside Ameliorates Senescence-Associated Alterations in Gastric Parietal Cells: Preclinical Findings


Synopsis

Aging causes widespread cellular decline, including in the gastrointestinal (GI) tract, where reduced digestive function and nutrient absorption often occur. This study examined how aging affects gastric parietal cells—the stomach cells responsible for producing acid—and whether nicotinamide riboside (NR), a vitamin B3–derived NAD+ precursor, could protect them. Older rats showed typical signs of cellular senescence, including reduced NAD+ levels, oxidative stress, DNA damage, and increased cell death, all of which impaired parietal cell structure and function. After three weeks of daily NR supplementation, aged rats had higher NAD+ levels, improved cellular structure, increased anti-apoptotic (Bcl-2) activity, and restored gastrin and pepsinogen-I secretion—both key to normal digestion. These findings suggest that NR can reverse aging-related stomach cell degeneration, enhance energy metabolism, and potentially prevent digestive decline and anemia associated with aging.

Journal

Egyptian Journal of Histology

Read more

Cellular Health

Comparative Analysis of Nicotinamide Mononucleotide and Nicotinamide Riboside in Protecting HeLa Cells From Cisplatin-Induced DNA Damage: Preclinical Findings

Synopsis Cisplatin, a common chemotherapy drug, works by damaging DNA in cancer cells—but it can also harm healthy cells, leading to side effects. This study compared two vitamin B3–derived NAD+ p...

Read more
Clinical

Nicotinamide Riboside Supplementation Supports Immune Regulation in Human Cells and Blood: Clinical Findings

Objectives To investigate how NR influences the migration of macrophages and the underlying mechanisms behind this effect. Journal Cells Key Outcomes Ex Vivo: NR treatment increased levels of NA...

Read more